Literature DB >> 25703805

Electromyographic findings in 37 patients with adult-onset acid maltase deficiency.

Charles D Kassardjian1, Andrew G Engel, Eric J Sorenson.   

Abstract

INTRODUCTION: In acid maltase deficiency (AMD), electrical myotonia (EM) may be restricted to paraspinal muscles. A comprehensive description of the electromyographic (EMG) findings in AMD is lacking. The purpose of this study is to describe the EMG features in adult-onset AMD, focusing on the distribution of EM.
METHODS: A retrospective chart review of AMD patients diagnosed at Mayo Clinic over age 18 years.
RESULTS: Thirty-seven patients were included. Twenty-eight (76%) had EM in at least 1 muscle, and EM was more common in paraspinal and proximal limb muscles. The tensor fasciae latae (TFL) was equally sensitive to the paraspinals for EM. Three of 4 patients had EM identified in the diaphragm.
CONCLUSIONS: Approximately three-quarters of adult-onset AMD patients display EM on EMG. The paraspinal muscles and TFL are the most likely to demonstrate EM, and EM can be detected in the diaphragm of adult onset AMD patients.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  EMG; Pompe disease; acid maltase deficiency; myotonia; myotonic discharge

Mesh:

Year:  2015        PMID: 25703805     DOI: 10.1002/mus.24620

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

Review 1.  Diagnostic tools in late onset Pompe disease (LOPD).

Authors:  Olimpia Musumeci; Antonio Toscano
Journal:  Ann Transl Med       Date:  2019-07

2.  Correcting Neuromuscular Deficits With Gene Therapy in Pompe Disease.

Authors:  Adrian G Todd; Jessica A McElroy; Robert W Grange; David D Fuller; Glenn A Walter; Barry J Byrne; Darin J Falk
Journal:  Ann Neurol       Date:  2015-06-30       Impact factor: 10.422

3.  Altered activation of the diaphragm in late-onset Pompe disease.

Authors:  Barbara K Smith; Manuela Corti; A Daniel Martin; David D Fuller; Barry J Byrne
Journal:  Respir Physiol Neurobiol       Date:  2015-11-28       Impact factor: 1.931

4.  Quantitative analysis of upright standing in adults with late-onset Pompe disease.

Authors:  Maria Stella Valle; Antonino Casabona; Agata Fiumara; Dora Castiglione; Giovanni Sorge; Matteo Cioni
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

5.  Pompe disease in Austria: clinical, genetic and epidemiological aspects.

Authors:  W N Löscher; M Huemer; T M Stulnig; P Simschitz; S Iglseder; C Eggers; H Moser; D Möslinger; M Freilinger; F Lagler; S Grinzinger; M Reichhardt; R E Bittner; W M Schmidt; U Lex; M Brunner-Krainz; S Quasthoff; J V Wanschitz
Journal:  J Neurol       Date:  2017-11-27       Impact factor: 4.849

6.  Quantification of intramuscular fat in patients with late-onset Pompe disease by conventional magnetic resonance imaging for the long-term follow-up of enzyme replacement therapy.

Authors:  André Lollert; Clemens Stihl; Andreas M Hötker; Eugen Mengel; Jochem König; Katharina Laudemann; Seyfullah Gökce; Christoph Düber; Gundula Staatz
Journal:  PLoS One       Date:  2018-01-09       Impact factor: 3.240

7.  Myofibrillar Myopathy Mimicking Polyneuropathy.

Authors:  Pierre R Bourque; Ari Breiner; Jodi Warman-Chardon
Journal:  Case Rep Neurol       Date:  2020-03-03

8.  Diagnostic modelling and therapeutic monitoring of immune-mediated necrotizing myopathy: role of electrical myotonia.

Authors:  James D Triplett; Shahar Shelly; Guy Livne; Margherita Milone; Charles D Kassardjian; Teerin Liewluck; Cecilia Kelly; Elie Naddaf; Ruple S Laughlin; Christopher J Lamb; Devon Rubin; Elliot L Dimberg; Divanshu Dubey; John R Mills; Jay Mandrekar; Christopher J Klein
Journal:  Brain Commun       Date:  2020-12-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.